Secrest Blakey & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$770K Sell
5,170
-51
-1% -$7.55K 1.76% 20
2020
Q2
$734K Sell
5,221
-97
-2% -$14.1K 1.77% 21
2020
Q1
$697K Sell
5,318
-89
-2% -$12.6K 1.9% 21
2019
Q4
$789K Sell
5,407
-5,853
-52% -$794K 1.74% 22
2019
Q3
$1.46M Buy
11,260
+304
+3% +$40.1K 1.2% 23
2019
Q2
$1.53M Buy
10,956
+183
+2% +$25.3K 1.33% 21
2019
Q1
$1.51M Sell
10,773
-2,976
-22% -$399K 1.46% 19
2018
Q4
$1.77M Buy
13,749
+101
+0.7% +$14.1K 1.48% 18
2018
Q3
$1.89M Sell
13,648
-40
-0.3% -$5.32K 1.45% 16
2018
Q2
$1.66M Buy
13,688
+689
+5% +$86K 1.31% 18
2018
Q1
$1.67M Sell
12,999
-1,325
-9% -$179K 1.42% 18
2017
Q4
$2M Buy
+14,324
New +$2M 1.62% 15

Other funds holding JNJ

Secrest Blakey & Associates's JNJ Position: Q3 2020 in Review

Secrest Blakey & Associates reduced its Johnson & Johnson (JNJ) stake by 0.98% in Q3 2020, selling an estimated $7.55K and leaving 5,170 shares worth $770K. The position accounts for 1.76% of the portfolio, ranked #20.

Secrest Blakey & Associates first reported a position in JNJ in Q4 2017 and has held it in 12 quarters since. The position peaked at $2M in Q4 2017. 2,985 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Secrest Blakey & Associates held 5,170 shares of Johnson & Johnson worth $770K as of Q3 2020.
  • Secrest Blakey & Associates sold 51 Johnson & Johnson shares in Q3 2020, an estimated $7.55K.
  • Johnson & Johnson made up 1.76% of Secrest Blakey & Associates's portfolio in Q3 2020, its #20 holding.
  • Secrest Blakey & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 12 quarters since.
  • Secrest Blakey & Associates's Johnson & Johnson position peaked at $2M in Q4 2017.
  • 2,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.